ProfileGDS4516 / 203016_s_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 93% 92% 93% 93% 92% 94% 92% 92% 91% 91% 93% 94% 93% 89% 93% 91% 94% 91% 94% 95% 92% 91% 92% 94% 89% 94% 91% 94% 88% 94% 91% 94% 87% 95% 89% 96% 89% 85% 85% 92% 94% 91% 90% 93% 91% 89% 94% 91% 93% 91% 95% 92% 92% 89% 95% 88% 93% 93% 94% 90% 94% 88% 95% 92% 86% 89% 90% 91% 94% 91% 95% 93% 91% 88% 89% 84% 93% 89% 94% 89% 90% 89% 97% 89% 94% 93% 90% 91% 91% 89% 91% 84% 88% 86% 83% 93% 91% 95% 87% 91% 93% 89% 88% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]10.049593
GSM537345patient 119, cancer, LCM [OPG study]9.6514992
GSM537355patient 138, cancer, LCM [OPG study]9.9319893
GSM537366patient 154, cancer, LCM [OPG study]9.975993
GSM537370patient 022, cancer, LCM [OPG study]10.013192
GSM537380patient 037, cancer, LCM [OPG study]10.389194
GSM537392patient 077, cancer, LCM [OPG study]9.8300692
GSM537415patient 032, cancer, LCM [OPG study]9.8388792
GSM537417patient 042, cancer, LCM [OPG study]9.2929991
GSM537422patient 059, cancer, LCM [OPG study]9.500191
GSM537423patient 064, cancer, LCM [OPG study]9.9933693
GSM537427patient 084, cancer, LCM [OPG study]10.317394
GSM537430patient 090, cancer, LCM [OPG study]9.8557993
GSM537336patient 107, cancer, LCM [OPG study]9.1810889
GSM537337patient 108, cancer, LCM [OPG study]9.8947893
GSM537348patient 124, cancer, LCM [OPG study]9.5169591
GSM537349patient 125, cancer, LCM [OPG study]10.376894
GSM537356patient 139, cancer, LCM [OPG study]9.5906791
GSM537361patient 147, cancer, LCM [OPG study]10.119694
GSM537374patient 026, cancer, LCM [OPG study]10.156495
GSM537377patient 033, cancer, LCM [OPG study]9.5831992
GSM537378patient 034, cancer, LCM [OPG study]9.6562791
GSM537379patient 036, cancer, LCM [OPG study]9.6066292
GSM537383patient 046, cancer, LCM [OPG study]10.391594
GSM537388patient 063, cancer, LCM [OPG study]9.2214789
GSM537395patient 082, cancer, LCM [OPG study]10.364594
GSM537400patient 099, cancer, LCM [OPG study]9.5233491
GSM537404patient 129, cancer, LCM [OPG study]9.9109294
GSM537409patient 141, cancer, LCM [OPG study]9.1308788
GSM537418patient 044, cancer, LCM [OPG study]10.346694
GSM537425patient 070, cancer, LCM [OPG study]9.521791
GSM537333patient 102, cancer, LCM [OPG study]10.219494
GSM537342patient 116, cancer, LCM [OPG study]8.8755187
GSM537347patient 123, cancer, LCM [OPG study]10.42295
GSM537350patient 127, cancer, LCM [OPG study]9.0070289
GSM537362patient 148, cancer, LCM [OPG study]10.840596
GSM537363patient 150, cancer, LCM [OPG study]9.1336989
GSM537368patient 156, cancer, LCM [OPG study]8.5472785
GSM537376patient 031, cancer, LCM [OPG study]8.4730485
GSM537381patient 038, cancer, LCM [OPG study]9.677592
GSM537386patient 057, cancer, LCM [OPG study]10.181594
GSM537398patient 094, cancer, LCM [OPG study]9.6282891
GSM537402patient 109, cancer, LCM [OPG study]9.3389790
GSM537405patient 130, cancer, LCM [OPG study]9.8673793
GSM537371patient 023, cancer, LCM [OPG study]9.6332291
GSM537421patient 055, cancer, LCM [OPG study]9.1195689
GSM537424patient 065, cancer, LCM [OPG study]10.022294
GSM537432patient 097, cancer, LCM [OPG study]9.4249191
GSM537331patient 100, cancer, LCM [OPG study]9.9649593
GSM537332patient 101, cancer, LCM [OPG study]9.4975391
GSM537334patient 103, cancer, LCM [OPG study]10.333295
GSM537338patient 110, cancer, LCM [OPG study]9.7022592
GSM537353patient 135, cancer, LCM [OPG study]9.880692
GSM537357patient 142, cancer, LCM [OPG study]9.2937289
GSM537358patient 143, cancer, LCM [OPG study]10.542395
GSM537375patient 030, cancer, LCM [OPG study]8.8853388
GSM537389patient 068, cancer, LCM [OPG study]10.258493
GSM537390patient 072, cancer, LCM [OPG study]10.123593
GSM537393patient 078, cancer, LCM [OPG study]10.282794
GSM537399patient 095, cancer, LCM [OPG study]9.0341690
GSM537407patient 133, cancer, LCM [OPG study]9.7915794
GSM537408patient 140, cancer, LCM [OPG study]9.0920588
GSM537428patient 086, cancer, LCM [OPG study]10.260195
GSM537354patient 136, cancer, LCM [OPG study]9.7904692
GSM537410patient 146, cancer, LCM [OPG study]8.7624486
GSM537413patient 027, cancer, LCM [OPG study]9.4152189
GSM537396patient 083, cancer, LCM [OPG study]9.3425190
GSM537397patient 088, cancer, LCM [OPG study]9.6816791
GSM537330patient 006, cancer, LCM [OPG study]10.356494
GSM537369patient 015, cancer, LCM [OPG study]9.5613991
GSM537373patient 025, cancer, LCM [OPG study]10.421295
GSM537401patient 106, cancer, LCM [OPG study]9.9704693
GSM537343patient 117, cancer, LCM [OPG study]9.4880291
GSM537367patient 155, cancer, LCM [OPG study]8.8811788
GSM537382patient 041, cancer, LCM [OPG study]9.1605389
GSM537385patient 053, cancer, LCM [OPG study]8.4086884
GSM537391patient 073, cancer, LCM [OPG study]9.8864193
GSM537419patient 045, cancer, LCM [OPG study]9.103589
GSM537420patient 052, cancer, LCM [OPG study]9.8086294
GSM537429patient 089, cancer, LCM [OPG study]9.3000589
GSM537431patient 096, cancer, LCM [OPG study]9.1265690
GSM537387patient 061, cancer, LCM [OPG study]9.1974589
GSM537414patient 028, cancer, LCM [OPG study]11.45797
GSM537433patient 098, cancer, LCM [OPG study]9.1089989
GSM537335patient 104, cancer, LCM [OPG study]10.395994
GSM537339patient 111, cancer, LCM [OPG study]10.252593
GSM537340patient 113, cancer, LCM [OPG study]9.2645190
GSM537344patient 118, cancer, LCM [OPG study]9.6032891
GSM537346patient 011, cancer, LCM [OPG study]9.5867191
GSM537351patient 128, cancer, LCM [OPG study]9.0207489
GSM537352patient 134, cancer, LCM [OPG study]9.5027991
GSM537359patient 144, cancer, LCM [OPG study]8.2785184
GSM537360patient 145, cancer, LCM [OPG study]9.1000188
GSM537364patient 152, cancer, LCM [OPG study]8.6862486
GSM537365patient 153, cancer, LCM [OPG study]8.3521283
GSM537372patient 024, cancer, LCM [OPG study]9.9447293
GSM537384patient 048, cancer, LCM [OPG study]9.5724291
GSM537394patient 081, cancer, LCM [OPG study]10.417595
GSM537403patient 121, cancer, LCM [OPG study]8.7688687
GSM537406patient 131, cancer, LCM [OPG study]9.3955791
GSM537411patient 149, cancer, LCM [OPG study]9.8873893
GSM537412patient 019, cancer, LCM [OPG study]9.1639789
GSM537416patient 035, cancer, LCM [OPG study]9.1349888
GSM537426patient 079, cancer, LCM [OPG study]9.4789990